ARTICLE | Company News
UC group strengthens CRISPR IP position in Europe
April 5, 2019 6:55 PM UTC
The European Patent Office issued a third patent covering broad CRISPR-Cas9 technology Wednesday to The Regents of the University of California, the University of Vienna and Emmanuelle Charpentier, further strengthening the group's IP position in Europe.
EP Patent No. 3,401,400 covers use of CRISPR-Cas9 in eukaryotic cells, including kits to perform such work...
BCIQ Target Profiles